Literature DB >> 903676

Maternal-fetal transfer of cefazolin in the first twenty weeks of pregnancy.

B Bernard, L Barton, M Abate, C A Ballard.   

Abstract

Maternal-fetal transfer of cefazolin was investigated with use of a single 14-mg/kg intramuscular dose administered to 40 gravidas before elective hysterectomy. The half-life of cefazolin in maternal serum was 1.5 hr with mean concentrations at 2 and 4 hr of 39 and 16 microgram/ml, respectively. By microbiological assay, cefazolin was not detected in brain, cerebrospinal fluid, lung, liver, or kidney of the fetus but was present in concentrations of 1-11 microgram/ml in 12 of 27 individual samples of fetal serum from 0.75 to 10.66 hr. Cefazolin appeared in fetal urine from 2.17 to 19.5 hr at levels of less than 5 microgram/ml with a half-life of 5.4 hr. Cefazolin was present in the amniotic fluid of fetuses older than 14 weeks in concentrations of less than 1 microgram/ml from 9 to 21.75 hr. After administration of a single dose to the mother early in pregnancy, the fetal distribution of cefazolin is limited to the body fluids.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903676     DOI: 10.1093/infdis/136.3.377

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Pharmacokinetic properties of the cephalosporins.

Authors:  T Bergan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Pharmacokinetics of antibiotics in pregnancy and labour.

Authors:  A Philipson
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

5.  Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum.

Authors:  D A Kafetzis; D C Brater; J E Fanourgakis; J Voyatzis; P Georgakopoulos
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 6.  Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors:  A Heikkilä; R Erkkola
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Ethical issues in pharmacologic research in women undergoing pregnancy termination: a systemic review and survey of researchers.

Authors:  Christelle Gedeon; Alejandro A Nava-Ocampo; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2011-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.